- UnitedHealth stock reels from medical cost ratio above 85% in Q3.
- 2025 outlook fails to live up to Wall Street expectations.
- Health insurer and care company beats Q3 consensus on top and bottom lines.
- Adjusted EPS, revenue rise 9% from a year ago.
UnitedHealth Group (UNH) stock, the largest holding in the Dow Jones Industrial Average (DJIA), sank 9% on Tuesday after the US’s largest health insurer reported costs in the third quarter exceeding prior guidance.
The medical care ratio, which compares insured costs compared to paid premiums, rose to 85.2% for the quarter ending in September. This compares noticeably with the quarter a year ago in which UnitedHealth saw a medical care ratio of 82.3%. Wall Street had expected a ratio of 84.4% in Q3.
The Dow Jones index slipped by half a percentage point on the news and was helped lower by another earnings report from Johnson & Johnson (JNJ). Earnings from Dow member Goldman Sachs (GS), however, helped the Wall Street bank rise 3%. The DJIA reached a fresh all-time high on Monday.
UnitedHealth stock earnings news
Despite the negative news on rising healthcare costs, UnitedHealth’s top and bottom lines for Q3 were quite impressive. The Minnesota-based insurer, which also has a managed care arm, reported an adjusted earnings per share (EPS) beat of 1.7%. Revenue in the quarter also beat the average Wall Street projection by 1.5%.
UnitedHealth earned $7.15 in adjusted EPS on revenue of $100.8 billion. This amounts to a 9% YoY rise in both adjusted EPS and revenue.
The UNH stock performance is affected by management’s full-year 2024 outlook of $15.50 to $15.75 per share in net income, which reflects charges to its South American operations and an expensive cyberattack that affected its Change Healthcare unit. That latter unit accounts for at least $0.75 per share in costs.
One good sign for shareholders is that the operating cost ratio fell from 15% one year ago to 13.2% in the quarter.
The UnitedHealthcare insurance unit saw revenues climb 7.2% YoY, while its healthcare services unit, Optum, saw a gain of 12.6% YoY.
Management lowered its full-year adjusted EPS outlook to between $27.50 and $27.75, down from an earlier top range of $28.00. Its 2025 guidance, however, really shocked its audience. Management just gave the round number of $30.00 for adjusted EPS in 2025. Bloomberg's data suggests that analysts expected something closer to $31.16.
UnitedHealth stock forecast
UNH stock has broken through its 100-day Simple Moving Average (SMA) on Tuesday. This is a significant happening. It means that the market will now look to the 200-day SMA near $525 as the nearest support. That level comports with a range high from May in its vicinity.
Longer-term support between $465 and $480 that held up most of the time in the first half of the year also comes into view. The lowest price of the year at $436.38 from April 12 can probably be disregarded. Healthcare premiums can be adjusted, and the overall business is extremely healthy in terms of turnover.
The market will forget about this earnings report once UNH stock overcomes the 50-day SMA, which is currently near $583.
UNH daily stock chart
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.
Recommended content
Editors’ Picks
EUR/USD holds steady above 1.0900 after earlier rebound
EUR/USD trades marginally higher on the day above 1.0900. According to the data from Germany and the Eurozone, ZEW Survey - Economic Sentiment improved more than expected in October, while the US data showed a sharp decline in NY Empire State Manufacturing Index.
GBP/USD clings to recovery gains above 1.3050 after UK data
GBP/USD stays in positive territory and edges higher toward 1.3100 on Tuesday. The data from the UK showed that the ILO Unemployment Rate declined to 4% in the three months to August, with Employment Change rising by 373K, helping Pound Sterling gain resilience.
Gold struggles to gather recovery momentum, holds above $2,650
Gold clings to small gains above $2,650 on Tuesday after closing the first day of the week virtually unchanged. Growing signs of an economic downturn in the Chinese economy makes it difficult for XAU/USD to gather recovery momentum.
Ethereum shows mild signs of recovery
Ethereum price broadly consolidates after breaking above its 50-day EMA at $2,535, suggesting a possible rally ahead. US spot Ethereum ETFs records an inflow of $17 million on Monday. Ethereum’s open interest surged more than 16%, indicating new buying activity.
RBA widely expected to keep key interest rate unchanged amid persisting price pressures
The Reserve Bank of Australia is likely to continue bucking the trend adopted by major central banks of the dovish policy pivot, opting to maintain the policy for the seventh consecutive meeting on Tuesday.
Five best Forex brokers in 2024
VERIFIED Choosing the best Forex broker in 2024 requires careful consideration of certain essential factors. With the wide array of options available, it is crucial to find a broker that aligns with your trading style, experience level, and financial goals.